ARCHIVES

Doxil/Caelyx Survival 3 Weeks Longer Than Topotecan

This article is from The Cancer Letter archive.

Vol. 26 No. 11 | November 28, 2003

Download PDF Visit The Full Archive

Related Articles

DeVita Appointment Now Official; Calls For New Chemoprevention Program, More Applied Prevention

July 18, 1980

Some Cancer Control Projects On Thin Ice As Board Eyes Funds For Others

January 29, 1982

White House To Appoint Richard Klausner, Molecular Biologist, As NCI’s 11th Director

July 28, 1995

Obey Continue Crusade On Carcinogenesis, Attack On DCCP, Shubik

April 1, 1977

Breast MRI Recipients More Likely To Choose Mastectomy

July 31, 2009

NCI advisors approved in concept the Institute’s plan to spend $24 million over five years for research on “patient navigator” programs.

March 26, 2004